View in EDS PDF Full Text

Corrigendum: Sorafenib increases cytochrome P450 lipid metabolites in patient with hepatocellular carcinoma.

Saved in:
Bibliographic Details
Title: Corrigendum: Sorafenib increases cytochrome P450 lipid metabolites in patient with hepatocellular carcinoma.
Authors: Leineweber CG; Medical Department B, Division of Hepatology, Gastroenterology, Oncology, Hematology, Palliative Care, Endocrinology, and Diabetes, Brandenburg Medical School, University Hospital Ruppin-Brandenburg, Neuruppin, Germany.; Faculty of Health Sciences, Joint Faculty of the Brandenburg University of Technology, Brandenburg Medical School and University of Potsdam, Potsdam, Germany.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Rabehl M; Medical Department B, Division of Hepatology, Gastroenterology, Oncology, Hematology, Palliative Care, Endocrinology, and Diabetes, Brandenburg Medical School, University Hospital Ruppin-Brandenburg, Neuruppin, Germany.; Faculty of Health Sciences, Joint Faculty of the Brandenburg University of Technology, Brandenburg Medical School and University of Potsdam, Potsdam, Germany., Pietzner A; Medical Department B, Division of Hepatology, Gastroenterology, Oncology, Hematology, Palliative Care, Endocrinology, and Diabetes, Brandenburg Medical School, University Hospital Ruppin-Brandenburg, Neuruppin, Germany.; Faculty of Health Sciences, Joint Faculty of the Brandenburg University of Technology, Brandenburg Medical School and University of Potsdam, Potsdam, Germany., Rohwer N; Medical Department B, Division of Hepatology, Gastroenterology, Oncology, Hematology, Palliative Care, Endocrinology, and Diabetes, Brandenburg Medical School, University Hospital Ruppin-Brandenburg, Neuruppin, Germany.; Faculty of Health Sciences, Joint Faculty of the Brandenburg University of Technology, Brandenburg Medical School and University of Potsdam, Potsdam, Germany.; Department of Molecular Toxicology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany., Rothe M; Lipidomix, Berlin, Germany., Pech M; Department of Radiology and Nuclear Medicine, Otto-von-Guericke University, Magdeburg, Germany., Sangro B; Liver Unit and HPB Oncology Area, Clinica Universidad de Navarra and CIBEREHD, Pamplona, Spain., Sharma R; Department of Surgery and Cancer, Imperial College London, London, United Kingdom., Verslype C; Department of Digestive Oncology, University Hospitals Leuven, Leuven, Belgium., Basu B; Department of Oncology, University of Cambridge, Cambridge, United Kingdom., Sengel C; Radiology Department, Grenoble University Hospital, La Tronche, France., Ricke J; Department of Radiology, University Hospital, Ludwig-Maximilians-University (LMU) Munich, Munich, Germany., Schebb NH; Chair of Food Chemistry, Faculty of Mathematics and Natural Science, University of Wuppertal, Wuppertal, Germany., Weylandt KH; Medical Department B, Division of Hepatology, Gastroenterology, Oncology, Hematology, Palliative Care, Endocrinology, and Diabetes, Brandenburg Medical School, University Hospital Ruppin-Brandenburg, Neuruppin, Germany.; Faculty of Health Sciences, Joint Faculty of the Brandenburg University of Technology, Brandenburg Medical School and University of Potsdam, Potsdam, Germany., Benckert J; Department of Hepatology and Gastroenterology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Source: Frontiers in pharmacology [Front Pharmacol] 2024 Jan 11; Vol. 14, pp. 1354581. Date of Electronic Publication: 2024 Jan 11 (Print Publication: 2023).
Publication Type: Published Erratum
Journal Info: Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38273836
AccessLevel: 2
PubTypeId: unknown
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Corrigendum: Sorafenib increases cytochrome P450 lipid metabolites in patient with hepatocellular carcinoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Leineweber+CG%22">Leineweber CG</searchLink>; Medical Department B, Division of Hepatology, Gastroenterology, Oncology, Hematology, Palliative Care, Endocrinology, and Diabetes, Brandenburg Medical School, University Hospital Ruppin-Brandenburg, Neuruppin, Germany.; Faculty of Health Sciences, Joint Faculty of the Brandenburg University of Technology, Brandenburg Medical School and University of Potsdam, Potsdam, Germany.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Rabehl+M%22">Rabehl M</searchLink>; Medical Department B, Division of Hepatology, Gastroenterology, Oncology, Hematology, Palliative Care, Endocrinology, and Diabetes, Brandenburg Medical School, University Hospital Ruppin-Brandenburg, Neuruppin, Germany.; Faculty of Health Sciences, Joint Faculty of the Brandenburg University of Technology, Brandenburg Medical School and University of Potsdam, Potsdam, Germany.<br /><searchLink fieldCode="AU" term="%22Pietzner+A%22">Pietzner A</searchLink>; Medical Department B, Division of Hepatology, Gastroenterology, Oncology, Hematology, Palliative Care, Endocrinology, and Diabetes, Brandenburg Medical School, University Hospital Ruppin-Brandenburg, Neuruppin, Germany.; Faculty of Health Sciences, Joint Faculty of the Brandenburg University of Technology, Brandenburg Medical School and University of Potsdam, Potsdam, Germany.<br /><searchLink fieldCode="AU" term="%22Rohwer+N%22">Rohwer N</searchLink>; Medical Department B, Division of Hepatology, Gastroenterology, Oncology, Hematology, Palliative Care, Endocrinology, and Diabetes, Brandenburg Medical School, University Hospital Ruppin-Brandenburg, Neuruppin, Germany.; Faculty of Health Sciences, Joint Faculty of the Brandenburg University of Technology, Brandenburg Medical School and University of Potsdam, Potsdam, Germany.; Department of Molecular Toxicology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.<br /><searchLink fieldCode="AU" term="%22Rothe+M%22">Rothe M</searchLink>; Lipidomix, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Pech+M%22">Pech M</searchLink>; Department of Radiology and Nuclear Medicine, Otto-von-Guericke University, Magdeburg, Germany.<br /><searchLink fieldCode="AU" term="%22Sangro+B%22">Sangro B</searchLink>; Liver Unit and HPB Oncology Area, Clinica Universidad de Navarra and CIBEREHD, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Sharma+R%22">Sharma R</searchLink>; Department of Surgery and Cancer, Imperial College London, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Verslype+C%22">Verslype C</searchLink>; Department of Digestive Oncology, University Hospitals Leuven, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Basu+B%22">Basu B</searchLink>; Department of Oncology, University of Cambridge, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Sengel+C%22">Sengel C</searchLink>; Radiology Department, Grenoble University Hospital, La Tronche, France.<br /><searchLink fieldCode="AU" term="%22Ricke+J%22">Ricke J</searchLink>; Department of Radiology, University Hospital, Ludwig-Maximilians-University (LMU) Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Schebb+NH%22">Schebb NH</searchLink>; Chair of Food Chemistry, Faculty of Mathematics and Natural Science, University of Wuppertal, Wuppertal, Germany.<br /><searchLink fieldCode="AU" term="%22Weylandt+KH%22">Weylandt KH</searchLink>; Medical Department B, Division of Hepatology, Gastroenterology, Oncology, Hematology, Palliative Care, Endocrinology, and Diabetes, Brandenburg Medical School, University Hospital Ruppin-Brandenburg, Neuruppin, Germany.; Faculty of Health Sciences, Joint Faculty of the Brandenburg University of Technology, Brandenburg Medical School and University of Potsdam, Potsdam, Germany.<br /><searchLink fieldCode="AU" term="%22Benckert+J%22">Benckert J</searchLink>; Department of Hepatology and Gastroenterology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101548923%22">Frontiers in pharmacology</searchLink> [Front Pharmacol] 2024 Jan 11; Vol. 14, pp. 1354581. <i>Date of Electronic Publication: </i>2024 Jan 11 (<i>Print Publication: </i>2023).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Published Erratum
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media]%22">Frontiers Media] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101548923 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1663-9812 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216639812%22">16639812 </searchLink><i>NLM ISO Abbreviation: </i>Front Pharmacol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38273836
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fphar.2023.1354581
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1354581
    Titles:
      – TitleFull: Corrigendum: Sorafenib increases cytochrome P450 lipid metabolites in patient with hepatocellular carcinoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Leineweber CG
      – PersonEntity:
          Name:
            NameFull: Rabehl M
      – PersonEntity:
          Name:
            NameFull: Pietzner A
      – PersonEntity:
          Name:
            NameFull: Rohwer N
      – PersonEntity:
          Name:
            NameFull: Rothe M
      – PersonEntity:
          Name:
            NameFull: Pech M
      – PersonEntity:
          Name:
            NameFull: Sangro B
      – PersonEntity:
          Name:
            NameFull: Sharma R
      – PersonEntity:
          Name:
            NameFull: Verslype C
      – PersonEntity:
          Name:
            NameFull: Basu B
      – PersonEntity:
          Name:
            NameFull: Sengel C
      – PersonEntity:
          Name:
            NameFull: Ricke J
      – PersonEntity:
          Name:
            NameFull: Schebb NH
      – PersonEntity:
          Name:
            NameFull: Weylandt KH
      – PersonEntity:
          Name:
            NameFull: Benckert J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 11
              M: 01
              Text: 2024 Jan 11
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 1663-9812
          Numbering:
            – Type: volume
              Value: 14
          Titles:
            – TitleFull: Frontiers in pharmacology
              Type: main
ResultId 1